Sign in

CIK 0001420565

  • Non-accelerated filer
  • Smaller reporting company

Rein Therapeutics, Inc.

Sign in to watch
Ticker
RNTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
134196017
Phone
+1 737-802-1989
Business address
12407 N. MOPAC EXPY., SUITE 250 #390, AUSTIN, TX, 78758
Former names
Aileron Therapeutics, Inc., AILERON THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-03-30 Wanstall Rick Grant or award · Stock Option (right to buy) +393,000 393,000
2022-03-22 Wanstall Rick Grant or award · Stock Option (right to buy) +393,000 393,000
2021-06-15 Wanstall Rick Grant or award · Stock Option (right to buy) +600,000 600,000
2020-06-23 Wanstall Rick Grant or award · Stock Option (right to buy) +91,000 91,000
2020-01-31 Wanstall Rick Grant or award · Stock Option (right to buy) +200,000 200,000
2019-04-15 Wanstall Rick VP, Finance and Operations Grant or award · Stock Option (right to buy) +59,000 59,000

Page 1 of 1 · 6 trades